October Pharma results, Q1 2022
Net profit, assets, equity and cash flow for Q1 2022, against the same period a year earlier, from the published financial statements.
Net profit40.97 millionEGP
Total assets638 millionEGP
Shareholders' equity336 millionEGP
Operating cash flow-27.3 millionEGP
In short
- October Pharma's net profit for Q1 2022 was about 40.97 million EGP.
- Total assets at the end of Q1 2022 were about 638 million EGP, and shareholders' equity about 336 million EGP.
- Operating cash flow for Q1 2022 was negative at 27.3 million EGP.
Key lines against the same period a year earlier
This periodYear earlierChange
Net profit40.97 million——
Gross profit93.29 million——
Total assets638 million——
Total liabilities302 million——
Shareholders' equity336 million——
Total liabilities and equity638 million——
Operating cash flow-27.3 million——
Investing cash flow-2.35 million——
Financing cash flow25.24 million——
Net change in cash-4.4 million——
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
October Pharma's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy